Merck (NYSE: MRK) reported its third quarter 2024 earnings results today.
Sales grew 4% year-over-year to $16.7 billion. Excluding FX, sales growth was 7%.
GAAP net income decreased 33% to $3.15 billion, or $1.24 per share, compared to last year. Adjusted EPS fell 26% to $1.57.
For the full year of 2024, the company expects sales of $63.6-64.1 billion and adjusted EPS of $7.72-7.77.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
AMZN Earnings: All you need to know about Amazon’s Q3 2024 earnings results
Amazon.com, Inc. (NASDAQ: AMZN) reported its third quarter 2024 earnings results today. Net sales increased 11% to $158.9 billion compared to the year-ago quarter. Net income was $15.3 billion, or
Key metrics from Bristol Myers Squibb’s (BMY) Q3 2024 earnings results
Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2024 earnings results today. Total revenues increased 8% year-over-year to $11.9 billion. Revenues grew 10%, excluding FX. Net earnings attributable to
Altria (MO) Q3 2024 Earnings: Key financials and quarterly highlights
Altria Group, Inc. (NYSE: MO) reported its third quarter 2024 earnings results today. Net revenues remained relatively unchanged at $6.25 billion compared to the same period a year ago. Net
